Subramanian Govindan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Production of glycoconjugate vaccines involves the chemical conjugation of glycans to an immunogenic carrier protein such as Cross-Reactive-Material-197 (CRM197). Instead of using glycans from natural sources recent vaccine development has been focusing on the use of synthetically defined minimal epitopes. While the glycan is structurally defined, the(More)
  • 1